Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS

PHASE4CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Chronic Prostatitis
Interventions
DRUG

Ningmitai capsule

Ningmitai capsule (Ningmitai®) is Traditional Chinese Medicine which has already used in treatment of urinary system disease (eg. CPPS, BPH) in China for more than twenty years. The instruction of Ningmitai Capsule is 0.38g/capsule, 4 capsule/time, tid.

DRUG

Celecoxib capsule

Celecoxib is one of NSAIDs recommended by the CUA Prostatitis Guidelines for alleviating pain symptoms in CP/CPPS patients. The instruction of Celecoxib capsule is 1 capsule at a time, 1 time a day.

DRUG

Ningmitai placebo

Ningmitai placebo, a look-alike substance that contains no active drug, similar to Ningmitai capsule in color, smell, taste, shape, texture and other characteristics, 0.38g/ capsule.

DRUG

Celecoxib placebo

Celecoxib placebo, a look-alike substance that contains no active drug, similar to Celecoxib capsule in color, smell, taste, shape, texture and other characteristics, 0.2g/ capsule.

Trial Locations (1)

Unknown

The First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

Xintian Pharmaceutical

INDUSTRY

NCT06159114 - Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS | Biotech Hunter | Biotech Hunter